BR9907216A - Mutantes de il-16, processos para sua produção e utilização dos mesmos - Google Patents

Mutantes de il-16, processos para sua produção e utilização dos mesmos

Info

Publication number
BR9907216A
BR9907216A BR9907216-5A BR9907216A BR9907216A BR 9907216 A BR9907216 A BR 9907216A BR 9907216 A BR9907216 A BR 9907216A BR 9907216 A BR9907216 A BR 9907216A
Authority
BR
Brazil
Prior art keywords
mutants
production
processes
nucleic acid
amino acids
Prior art date
Application number
BR9907216-5A
Other languages
English (en)
Portuguese (pt)
Inventor
Reinhard Kurth
Michael Baier
Albrecht Werner
Dorothee Ambrosius
Martin Lanzendoerfer
Original Assignee
Bundesrep Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bundesrep Deutschland filed Critical Bundesrep Deutschland
Publication of BR9907216A publication Critical patent/BR9907216A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BR9907216-5A 1998-01-24 1999-01-22 Mutantes de il-16, processos para sua produção e utilização dos mesmos BR9907216A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98101232 1998-01-24
PCT/EP1999/000428 WO1999037781A1 (en) 1998-01-24 1999-01-22 Mutants of il-16, processes for their production, and their use

Publications (1)

Publication Number Publication Date
BR9907216A true BR9907216A (pt) 2000-10-24

Family

ID=8231307

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9907216-5A BR9907216A (pt) 1998-01-24 1999-01-22 Mutantes de il-16, processos para sua produção e utilização dos mesmos

Country Status (8)

Country Link
EP (1) EP1049782A1 (es)
JP (1) JP2002500889A (es)
AU (1) AU2424399A (es)
BR (1) BR9907216A (es)
CA (1) CA2320624A1 (es)
EA (1) EA200000769A1 (es)
MX (1) MXPA00006059A (es)
WO (1) WO1999037781A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6699466B1 (en) 1999-08-05 2004-03-02 Research Corporation Technologies, Inc. IL-16 antagonist peptides and DNA encoding the peptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028134A1 (en) * 1993-05-21 1994-12-08 The Trustees Of Boston University Lymphocyte chemoattractant factor and uses thereof
CA2239704A1 (en) * 1995-12-22 1997-07-03 Bundesrepublik Dutschland, Vertreten Durch Den Bundesminister Fur Gesundheit Polypeptides with interleukin 16 activity, process for the preparation and use thereof
DE19617202A1 (de) * 1996-04-30 1997-11-06 Boehringer Mannheim Gmbh Prozessierte Polypeptide mit IL-16-Aktivität, Verfahren zu ihrer Herstellung und Verwendung
US6444202B1 (en) * 1996-11-25 2002-09-03 Bundesrepublic Deutschland, Vertreten Durch Den Bundesminister Fur Gesundheit Processed polypeptides with IL-16 activity, processes for their production and their use

Also Published As

Publication number Publication date
CA2320624A1 (en) 1999-07-29
WO1999037781A1 (en) 1999-07-29
EA200000769A1 (ru) 2001-02-26
JP2002500889A (ja) 2002-01-15
EP1049782A1 (en) 2000-11-08
MXPA00006059A (es) 2003-08-01
AU2424399A (en) 1999-08-09

Similar Documents

Publication Publication Date Title
BR0207325A (pt) Métodos terapêuticos para doenças associadas com expressão diminuìda de gene de aop-1 ou aop-1
BR9904955A (pt) Dna bactéria pertencendo ao gênero escherichia, e, processo para produzir um aminoácido.
WO2001079462A3 (en) Nucleic acids encoding polypeptides having haloperoxidase activity
HUP0103414A2 (hu) Amiloszacharázt kódoló nukleinsav molekulák
WO1998014592A3 (en) Telomerase reverse transcriptase
WO1996017924A3 (en) Novel hedgehog-derived polypeptides
DE50013610D1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
BR9814834A (pt) Segmentos purificado e isolado de ácido nucleico, vetor recombinante, células hospedeira recombinante, e hospedeira procariótica ou eucariótica, composições purificada, e farmacêutica, processos para detectar uma espécie de dna, para detectar uma célula bacteriana que expresse o mrna que codifica a streptococcus equisimilis hialuronan sintase, e para produzir ácido hialurÈnico, sequênica de ácido nucleico purificada e isolada, e, sequência de cdna
DE60034688D1 (de) Kristallstruktur einer deacetylase und deren inhibitoren
Kim et al. The structural organization of the hamster multifunctional protein CAD. Controlled proteolysis, domains, and linkers.
Shlyapnikov et al. Primary structure of cytoplasmic aspartate aminotransferase from chicken heart and its homology with pig heart isoenzymes
NO972313L (no) Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav
BR9907216A (pt) Mutantes de il-16, processos para sua produção e utilização dos mesmos
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
ATE340257T1 (de) Histonedeacetylase 9
ES2168282T3 (es) D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion.
ATE361363T1 (de) Impfstoff, der peroxiredoxin enthält
ZA874430B (en) New polypeptides,their preparation and use
BR9709205A (pt) Polipeptìdeos processados com arividade de il-16, processos para a sua produção e seu uso
BR9810990A (pt) Dna-bactéria corineforme, e processos para produzir acido l-glutâmico, e, para produzir l-lisina e ácido l-glutâmico.
PT1322753E (pt) Novas redutases do acido 2,5-diceto-l-gluconico e metodos de utilizacao
BR9808625A (pt) O uso de proteìnas extraìveis de órgãos de animal para a preparação de medicamentos para o tratamento de condições patológicas caracterizadas por hiperprodução de fator de necrose de tumor (tnf)
PE47599A1 (es) Proteinas antiobesidad
DE69737561D1 (de) Klonierte rezeptoren des glukagon-ähnlichen peptids-2
DE60216073D1 (de) Peptidylarginin deiminase 6

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.